Search Results

Provider

Kevin M Flanigan

Kevin M. Flanigan, MD, is an attending neurologist at Nationwide Children's and director of the Jerry R. Mendell Center for Gene Therapy in the Abigail Wexner Research Institute at Nationwide Children's Hospital.

Article

March 2013

Dr. Louise Rodino-Klapac discusses alpha 7 integrin as A therapeutic approach to muscular dystrophy.

Article

January 2015

Dr. Louise Rodino-Klapac discusses dysferlin overlap vectors to restore function in dysferlinopathies.

Article

February 2012

Dr. Burghes discusses antisense oligomer treatment in an SMA mouse model.

Article

July 2012

Dr. Louise Rodino-Klapac discusses advances in dysferlin gene therapy.

Article

May 2012

Dr. Hugh Allen discusses cardiomyopathy in duchenne muscular dystrophy.

Article

March 2012

Dr. Thomas Voit discusses gamma sarcoglycan gene therapy.

Article

June 2013

Dr. Paul Martin discusses Galgt2 gene therapy for muscular dystrophy.

Article

Flanigan Lab

Under the direction of Kevin Flanigan, MD, the Flanigan Lab focuses on the genetic and molecular characterization of inherited neuromuscular diseases, and toward the development of therapies directed toward these diseases.

Most Popular Pages
Specialty

Asthma Program

Specialty

Clinical Therapies

Condition

Headaches

Condition

Nasal Congestion